Table 4: Types of drug and reason for initial ART regimen change at NGH from 2006 to 2016.
| Start Regimen |
Toxicity |
Treatment Failure |
Tuberculosis |
Pregnancy |
New Drug Available |
Drug Out of Stock |
Total |
| D4T+3TC+NVP |
13 (11.1%) |
3 (2.6%) |
4 (3.4%) |
- |
36 (30.8%) |
- |
56 (47.9%) |
| D4T+3TC+EFV |
3 (2.6%) |
2 (1.7%) |
1 (0.9%) |
- |
10 (8.5%) |
- |
30 (25.6%) |
| AZT+3TC+NVP |
14 (12%) |
2 (1.7%) |
11 (9.4%) |
2 (1.7%) |
0 (0%) |
1 (0.9%) |
16 (13.7%) |
| AZT+3TC+EFV |
1 (0.9%) |
5 (4.3%) |
- |
- |
- |
- |
6 (5.1%) |
| TDF+3TC+EFV |
3 (2.6%) |
- |
- |
- |
- |
- |
6 (5.1%) |
| TDF+3TC+NVP |
0 (0%) |
0 (0%) |
5 (4.2%) |
1 (0.9%) |
- |
- |
3 (2.6%) |
| Total |
34 (29.2%) |
12 (10.3% |
21 (17.9%) |
3 (2.6%) |
46 (39.3% |
1 (0.9% |
117(100%) |